BRPI0921625A2 - composicoes baseadas em d-tagatose e metodos para previnir e tratar aterosclerose, sindrome metabolica, e sintomas dos mesmos - Google Patents

composicoes baseadas em d-tagatose e metodos para previnir e tratar aterosclerose, sindrome metabolica, e sintomas dos mesmos

Info

Publication number
BRPI0921625A2
BRPI0921625A2 BRPI0921625A BRPI0921625A BRPI0921625A2 BR PI0921625 A2 BRPI0921625 A2 BR PI0921625A2 BR PI0921625 A BRPI0921625 A BR PI0921625A BR PI0921625 A BRPI0921625 A BR PI0921625A BR PI0921625 A2 BRPI0921625 A2 BR PI0921625A2
Authority
BR
Brazil
Prior art keywords
tagatose
symptoms
preventing
methods
metabolic syndrome
Prior art date
Application number
BRPI0921625A
Other languages
English (en)
Inventor
Lisa A Cassis
Robbert A Lodder
Original Assignee
Univ Kentucky Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kentucky Res Foundation Inc filed Critical Univ Kentucky Res Foundation Inc
Publication of BRPI0921625A2 publication Critical patent/BRPI0921625A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
BRPI0921625A 2008-11-04 2009-11-04 composicoes baseadas em d-tagatose e metodos para previnir e tratar aterosclerose, sindrome metabolica, e sintomas dos mesmos BRPI0921625A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19319208P 2008-11-04 2008-11-04
PCT/US2009/063293 WO2010054001A2 (en) 2008-11-04 2009-11-04 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof

Publications (1)

Publication Number Publication Date
BRPI0921625A2 true BRPI0921625A2 (pt) 2016-01-05

Family

ID=42153532

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921625A BRPI0921625A2 (pt) 2008-11-04 2009-11-04 composicoes baseadas em d-tagatose e metodos para previnir e tratar aterosclerose, sindrome metabolica, e sintomas dos mesmos

Country Status (7)

Country Link
US (2) US9060962B2 (pt)
EP (1) EP2352505B1 (pt)
JP (1) JP2012506912A (pt)
CN (1) CN102238954A (pt)
BR (1) BRPI0921625A2 (pt)
RU (1) RU2484827C2 (pt)
WO (1) WO2010054001A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2484827C2 (ru) * 2008-11-04 2013-06-20 Юниверсити Оф Кентукки Рисерч Фаундэйшн Композиции на основе d-тагатозы и способы предупреждения и лечения атеросклероза, метаболического синдрома и их симптомов
JP6061482B2 (ja) * 2012-03-21 2017-01-18 株式会社山田養蜂場本社 アンジオテンシンｉｉ１型受容体拮抗剤及び血圧降下剤
CN103275044B (zh) * 2013-06-14 2015-01-14 中国药科大学 一种r型白藜芦醇二聚体、其制备方法及其降血糖用途
KR101475620B1 (ko) * 2013-08-13 2014-12-22 영남대학교 산학협력단 타가토스를 유효성분으로 함유하는 염증 또는 지방간 개선용 식의약품 첨가제
JP2015071549A (ja) * 2013-10-02 2015-04-16 株式会社ファンケル アトロジン−１抑制剤

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
JPS608000B2 (ja) * 1980-04-11 1985-02-28 呉羽化学工業株式会社 アミノフエニル誘導体及び該誘導体を含有する生理活性剤
US4786722A (en) 1986-08-29 1988-11-22 Biospherics Incorporated D-tagatose as a low-calorie carbohydrate sweetener and bulking agent
CA2077257C (en) 1989-07-19 2002-02-19 James R. Beadle Process for manufacturing tagatose
US5002612A (en) 1989-07-19 1991-03-26 Biospherics Incorporated Process for manufacturing tagatose
JPH0665080B2 (ja) 1989-08-30 1994-08-22 松下電器産業株式会社 電線の接続装置
US5356879A (en) 1992-02-14 1994-10-18 Biospherics, Incorporated D-tagatose as anti-hyperglycemic agent
JPH0665080A (ja) 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
US20020107222A1 (en) 1993-03-01 2002-08-08 David Platt Modified polysaccharides for treatment of cancer
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
ATE238694T1 (de) 1998-01-05 2003-05-15 Arla Foods Amba Verwendung von t-tagatose als synergist und geschmacksverstaerker
US7202219B1 (en) 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
EP1495681A3 (en) 1998-03-04 2005-05-25 Dandy A/S A coated chewing gum, a method for preparation thereof and the use of one or more active substances in the coating
WO2000007454A1 (fr) 1998-08-07 2000-02-17 Societe Des Produits Nestle S.A. Produit laitier anti-cariogene et son utilisation
WO2000042865A2 (en) * 1999-01-19 2000-07-27 Kellogg Company Rte cereals presweetened with d-tagatose
DE60030845T2 (de) * 1999-01-29 2007-05-03 Sunstar Inc., Takatsuki Arzneimittel, lebensmittel und orale zusammensetzungen die stilben-artige verbindungen enthalten
US20040220115A1 (en) 1999-04-09 2004-11-04 Cham Bill E Medicinal compositions and their method of preparation
US6225452B1 (en) 1999-04-26 2001-05-01 Biospherics Incorporated Increased fertility and improved fetal development drug
US6015793A (en) * 1999-04-26 2000-01-18 Biospherics Incorporated Use of tagatose to enhance key blood factors
US20050233459A1 (en) 2003-11-26 2005-10-20 Melker Richard J Marker detection method and apparatus to monitor drug compliance
DE19961338A1 (de) 1999-12-17 2001-06-21 Nutrinova Gmbh Feste Mischung von Lebensmittelinhalts- und Lebensmittelzusatzstoffen, Verfahren zu ihrer Herstellung und Verwendung derselben
US20040028772A1 (en) 2000-08-14 2004-02-12 Carsten Andersen Method for preparation of chewing gum with customer acceptable taste
US6355409B1 (en) 2000-09-01 2002-03-12 Biospherics Incorporated Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury
GB0022719D0 (en) 2000-09-15 2000-11-01 Mars Uk Ltd Food product
WO2002058710A1 (en) * 2001-01-25 2002-08-01 University Of Maryland, Baltimore Tagatose as a novel treatment for metabolic syndrome x, dyslipidemia, and coronary artery disease
US20020137725A1 (en) * 2001-03-20 2002-09-26 Levin Gilbert V. Use of tagatose in promoting cardiovascular health
US20020197352A1 (en) 2001-04-02 2002-12-26 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US6989171B2 (en) 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20020187232A1 (en) 2001-05-01 2002-12-12 Thomas Lee Method of improving the taste of low-calorie beverages and food products
US20060068072A9 (en) 2001-04-27 2006-03-30 Pepsico, Inc. Use of erythritol and D-tagatose in diet or reduced-calorie beverages
US8227006B2 (en) 2001-04-27 2012-07-24 Pepsico, Inc. Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
WO2002087358A1 (en) 2001-05-01 2002-11-07 Pepsico, Inc. Use of erythritol and d-tagatose in zero- or low-calorie beverages and food products
DE10124475A1 (de) * 2001-05-19 2002-11-21 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einer oder mehreren Kethohexosen
US6991923B2 (en) 2001-07-16 2006-01-31 Arla Foods Amba Process for manufacturing of tagatose
US7189351B2 (en) 2001-10-25 2007-03-13 Spherix Incorporated D-tagatose as an anti-biofilm agent
US20030099602A1 (en) 2001-10-25 2003-05-29 Levin Gilbert V. D-tagatose as an anti-biofilm agent
KR20050002828A (ko) * 2002-02-21 2005-01-10 멤파일 인크. 중합체 결합된 공여체-수용체-공여체 화합물 및 3-차원광학 메모리에서의 그의 용도
DE10392417T5 (de) * 2002-03-21 2005-07-07 Spherix Inc. Verwendung von Tagatose in Laxanzien
US20040053857A1 (en) 2002-07-01 2004-03-18 Solbec Pharmaceuticals Limited Glycoalkaloid compositions and various uses thereof
WO2004007423A1 (en) 2002-07-12 2004-01-22 Atherogenics, Inc. Novel salt forms of poorly soluble probucol esters and ethers
US20040037868A1 (en) 2002-08-20 2004-02-26 Minich Deanna M. Select prebiotics for use in weight attenuation message and method of communication
BR0313714A (pt) 2002-08-28 2005-06-28 Pharmacia Corp Composição oral de tolterodina lìquida
DE10248632A1 (de) 2002-09-23 2004-04-01 Sustech Gmbh & Co. Kg Umhüllter Kaugummi
EP1555985A1 (en) 2002-10-22 2005-07-27 L'oreal Heat activated durable styling compositions comprising saccharide type compounds and film forming agents
MXPA05007654A (es) * 2003-01-17 2005-09-30 Danisco Metodo.
MXPA05008138A (es) 2003-01-31 2006-02-17 Los Angeles Childrens Hospital Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas.
US20060159801A1 (en) 2003-02-20 2006-07-20 Kurt Rosenplenter Use of d-tagatose for improving aroma taste
BRPI0413581A (pt) 2003-08-14 2006-10-17 Cargill Inc composições de goma de mascar compreendendo monatina e métodos para preparar as mesmas
BRPI0413931A (pt) 2003-08-25 2006-10-24 Cargill Inc composições de bebida compreendendo monatina e métodos para sua fabricação
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US20050282773A1 (en) 2004-01-14 2005-12-22 Pro-Pharmaceuticals, Inc. Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer
US8734873B2 (en) 2004-04-07 2014-05-27 Archer Daniels Medical Company Food bar with reduced hardness
TWI356713B (en) 2004-06-01 2012-01-21 Nycomed Pharma As Chewable, suckable and swallowable tablet containi
US20060024351A1 (en) 2004-07-28 2006-02-02 Diane Bradford Hydrating breath freshening beverage compositions and method therefor
EP1791442B1 (en) 2004-07-30 2010-02-24 V.B. Medicare Pvt. Ltd. Reduced calorie sweetener composition
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
EP1817964A1 (en) 2006-02-13 2007-08-15 Sweetwell NV Functional sugar replacement
US20070082104A1 (en) 2004-08-12 2007-04-12 Sophie De Baets Functional sugar replacement
US20060062734A1 (en) 2004-09-20 2006-03-23 Melker Richard J Methods and systems for preventing diversion of prescription drugs
US20060073255A1 (en) 2004-10-04 2006-04-06 Steve Catani Non-hygroscopic, low-or no-calorie sugar substitute
US20060088637A1 (en) 2004-10-22 2006-04-27 Sweetsue Llc Sugar substitute and bulking agent and chocolate
WO2006058092A2 (en) 2004-11-22 2006-06-01 Cargill, Incorporated Monosaccharide production system
WO2006063219A2 (en) 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
CA2595883A1 (en) 2005-01-28 2006-08-03 Gumlink A/S Chewing gum piece and process for making the same
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
WO2006108592A1 (de) 2005-04-15 2006-10-19 Keme Food Engineering Ag Instantprodukt
JP4500874B2 (ja) 2005-05-23 2010-07-14 キャドバリー アダムス ユーエスエー エルエルシー 味覚増強剤組成物及び味覚増強剤組成物を含有する飲料
US7851005B2 (en) 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
EP2368442B1 (en) 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
WO2007032962A2 (en) 2005-09-09 2007-03-22 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
US20070059419A1 (en) 2005-09-13 2007-03-15 Catani Steven J Methods and compositions to improve mouth feel
US20070059421A1 (en) 2005-09-13 2007-03-15 Catani Steven J Methods and compositions to improve the palatability of foods
US20070059418A1 (en) 2005-09-13 2007-03-15 Catani Steven J Self-mixing tabletop sweetener
US20070116823A1 (en) 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener for hydration and sweetened hydration composition
US8993027B2 (en) 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
CA2634479C (en) * 2005-12-23 2013-02-05 Universite De Geneve Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same
JP2009523027A (ja) 2006-01-11 2009-06-18 アテューン フーズ プロバイオティック食品、その調製のためのプロセスおよび摂取量の管理
US20070212453A1 (en) 2006-03-08 2007-09-13 Niness Kathy R Botanical dispersions
FR2900153B1 (fr) 2006-04-21 2008-07-18 Rhodia Recherches & Tech Procede de condensation de motifs silyles a l'aide d'un catalyseur de type carbene
US20070259090A1 (en) 2006-05-05 2007-11-08 Technology Advancement Labs Llc Low-calorie foods and process of making the same
US20100048714A1 (en) * 2006-06-19 2010-02-25 University Of Utah Research Foundation Methods and Compositions Related to Inhibition of Ceramide Synthesis
US8333997B2 (en) 2006-06-21 2012-12-18 Albert Einstein College Of Medicine Of Yeshiva University Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
US7972859B2 (en) 2006-06-27 2011-07-05 Authentix, Inc. Authentication of ingestible products using saccharides as markers
CA2653732C (en) 2006-06-27 2013-09-10 Mars, Incorporated An indulgent edible composition
US20080014331A1 (en) 2006-07-17 2008-01-17 Constantin Badalov Super sweet sugar crystals and syrups for health and method
AU2007287208B2 (en) 2006-08-23 2012-11-29 Century Biologicals Private Limited Water formulation with herbal hint and a process therefor
US20080069933A1 (en) 2006-09-18 2008-03-20 ISON Renny Low-calorie cohesive non-free flowing sweetener compositions with decreased volume
US20080081093A1 (en) 2006-09-18 2008-04-03 ISON Renny Cohesive non-free flowing sweetener compositions containing a gluing agent
US20080069938A1 (en) 2006-09-18 2008-03-20 ISON Renny Cohesive non-free flowing sweetener compositions including low-calorie ingredients
US20080069934A1 (en) 2006-09-18 2008-03-20 ISON Renny Cohesive non-free flowing sweetener compositions containing disintegrant
US20080069935A1 (en) 2006-09-18 2008-03-20 ISON Renny Cohesive non-free flowing sweetener compositions including low-density ingredients
US20080069937A1 (en) 2006-09-18 2008-03-20 ISON Renny Balancing heat of solution in non-free flowing sweetener compositions
US20080069936A1 (en) 2006-09-18 2008-03-20 ISON Renny Cohesive non-free flowing sweeetener compositions containing a hygroscopic gluing agent and a desiccant
US20080085354A1 (en) 2006-10-06 2008-04-10 Teresa Marie Paeschke Controlled hydration of hydrocolloids
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20080107787A1 (en) 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
KR101290608B1 (ko) 2006-11-10 2013-07-30 고쿠리츠다이가쿠호우징 카가와다이가쿠 희소당을 포함하는 비우식성 소재 및 항우식제
JP5633952B2 (ja) * 2006-11-17 2014-12-03 松谷化学工業株式会社 Ｄ−プシコースを有効成分とするグルコキナーゼの核から細胞質への移行の促進剤
US8137946B2 (en) 2006-11-27 2012-03-20 Cj Cheiljedang Corporation Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same
FI20065815A0 (fi) 2006-12-15 2006-12-15 Danisco Sweeteners Oy Makeistuote, joka sisältää vettä, kiteytyvää makeuttajaa ja betaiinia, menetelmä makeistuotteen valmistamiseksi ja betaiinin käyttö makeistuotteessa
US20080226776A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Tea extracts for reducing off-taste of non-nutritive sweeteners
US20080226788A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Lhg compositions for reducing lingering bitter taste of steviol glycosides
US20080226799A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Diet Cola Beverages
US20080226789A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage products with non-nutritive sweetener and bitterant
US20080226790A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Long chain fatty acids for reducing off-taste of non-nutritive sweeteners
US20080260837A1 (en) 2007-04-20 2008-10-23 Qpharma, L.L.C. Physically stable aqueous suspensions of active pharmaceuticals
US20080260925A1 (en) 2007-04-23 2008-10-23 Galen Paul Zink Means for replacing common sugars if foods for enhanced nutrition
US20080292765A1 (en) 2007-05-22 2008-11-27 The Coca-Cola Company Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
US20090155363A1 (en) 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
WO2009080025A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising metformin
EP2240159A2 (en) 2008-02-05 2010-10-20 Actavis Group PTC EHF Alendronate formulations, method of making and method of use thereof
CN104193723B (zh) 2008-02-06 2019-05-31 西诺米克斯公司 增甜剂组合物及其制备方法
US20090214729A1 (en) 2008-02-26 2009-08-27 General Mills Ip Holdings Ii, Llc. Low caloric density aerated confections and methods of preparation
JP4915959B2 (ja) 2008-04-14 2012-04-11 松谷化学工業株式会社 砂糖様味質をもつ新規甘味料、その製造法および用途
MX2010012248A (es) 2008-05-09 2010-11-30 Cargill Inc Edulcorante, metodos de preparacion y aplicaciones del mismo.
JP5749880B2 (ja) 2008-05-27 2015-07-15 松谷化学工業株式会社 Ｄ−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤
US20090304759A1 (en) 2008-06-09 2009-12-10 E. I. Dupont De Nemours And Company Chitosan/sugar composite films and laminates made therefrom
JP2010032732A (ja) 2008-07-28 2010-02-12 Panasonic Corp 液晶表示装置
CA2732098C (en) 2008-07-31 2016-11-22 Senomyx, Inc. Compositions comprising sweetness enhancers and methods of making them
RU2484827C2 (ru) * 2008-11-04 2013-06-20 Юниверсити Оф Кентукки Рисерч Фаундэйшн Композиции на основе d-тагатозы и способы предупреждения и лечения атеросклероза, метаболического синдрома и их симптомов
US20100160243A1 (en) 2008-12-24 2010-06-24 National Yang-Ming University Compounds and methods for enhancing erythropoiesis

Also Published As

Publication number Publication date
WO2010054001A2 (en) 2010-05-14
WO2010054001A3 (en) 2010-08-19
JP2012506912A (ja) 2012-03-22
EP2352505B1 (en) 2016-07-06
US20150250810A1 (en) 2015-09-10
US9060962B2 (en) 2015-06-23
RU2484827C2 (ru) 2013-06-20
RU2011122598A (ru) 2012-12-20
CN102238954A (zh) 2011-11-09
EP2352505A4 (en) 2012-05-02
US20110263518A1 (en) 2011-10-27
EP2352505A2 (en) 2011-08-10

Similar Documents

Publication Publication Date Title
BRPI0920326A2 (pt) composição e método para tratamento da síndrome do olho ressecado
BRPI1013878A2 (pt) método para tratar distúrbios metabólicos, e, composto
BRPI0916926A2 (pt) tecnologia sms para dispositivos computadorizados
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI1008357A2 (pt) dispositivo de autenticação, método de autenticação, e programa para execução deste por computador
BR112014009528A2 (pt) métodos e composições para tratar eritropoiese ineficaz
BRPI0913165A2 (pt) método para detectar malware em dispositivos de computação
BRPI0919575A2 (pt) método, e, composição
BRPI0918813A2 (pt) biopolímero de lignina modificado útil em composições para limpeza
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0923090A2 (pt) método implementado por computador
BRPI0909627A2 (pt) métodos, composições e kits para tratar dores e pruridos
BRPI1009598A2 (pt) aparelho para redução do ronco, método para redução do ronco e programa de computador para redução do ronco
BRPI0823277A2 (pt) Composição, e , método
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0919813A2 (pt) aparelho de exercício e método para operar aparelho de exercício
BR112012004475A2 (pt) computador servidor de notificação, e, método
EP2464371A4 (en) METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
BRPI0911083A8 (pt) métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos
BR112013009485A2 (pt) compostos, composições e métodos úteis para mobilização de colesterol
BRPI0917496A2 (pt) metodo para realizacao de adaptacao de conteudos e servidor de adaptacao de conteudos
BRPI0822472A2 (pt) Método, camundongo, e, composição
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
BRPI0823238A2 (pt) Composição, e, método

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.